PT Tempo Scan Pacific Tbk (PEXXF) 股价，以美元计价

PT Tempo Scan Pacific Tbk and its subsidiaries (Company) constitute the Tempo Group, a national private group of companies which started trading business of pharmaceutical products since 1953. PT Tempo Scan Pacific Tbk was formerly named PT Scanchemie which commenced large-scale commercial production of pharmaceutical products in 1970. In time, the Company through its subsidiary companies expanded its operations to include production of cosmetics and consumer products in 1977. In 1994, the Company became a public company, listing a total of 75,000,000 shares in the Indonesian Stock Exchange (BEI). In 1995, the said total number of shares became 150,000,000 shares, due to the change of the nominal value of each Company’s share from Rp. 1,000 to Rp. 500 per share (stock split). Further in 1998, BEI agreed to list 300,000,000 shares of the Company’s shares coming from its First Limited Public Offering, hence the Company’s total number of listed shares became 450,000,000 shares. In 2006, the total number of listed shares increased to 4,500,000,000 shares due to the change of the nominal value of each Company’s share from Rp. 500 to Rp. 50 per share (stock split). On 31 December 2010, more than 95% of the Company’s shares were owned by PT Bogamulia Nagadi and the remaining almost 5% were owned by the public with respective ownership of less than 5%. At the end of 2010, the Company’s market capitalization was Rp. 7.695 trillion. As of 31 December 2010 the Company has approximately 5,400 permanent employees. The Company has three Core Business Divisions, namely Pharmaceutical Division, Consumer Products and Cosmetics Division and Distribution Division and also one Supporting Division.